Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Entelos Pen 2-Year Alliance to Study Metabolic Diseases

NEW YORK, May 24 (GenomeWeb News) - Roche and Entelos have inked a two-year collaboration to research metabolic diseases, the companies said today.


Under the terms of the agreement, Roche will provide Entelos with R&D funding and milestone payments for biosimulation research conducted using its Metabolism PhysioLab platform, the companies said.


Roche said that Entelos' approach could be "useful in analyzing existing preclinical and clinical data in order to optimize future clinical trials" for drugs or tests that treat chronic metabolic disorders like diabetes and obesity.


Financial terms were not disclosed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.